Panel: Pharma’s Structural Shift: What’s Reshaping Global Priorities

The pharmaceutical industry is being reshaped by three major forces: economic pressures from pricing reforms, geopolitical shifts as countries prioritise medicine security, and rapid scientific advances in new therapies and digital tools. These changes are forcing companies to rethink long-standing approaches to supply chains, investment, and market access. This panel explores how leaders are responding, where innovation meets infrastructure limits, where policy goals clash with business realities, and how regional differences are creating new competitive dynamics.

This session is available to attendees with a Leader or Networking Leader pass.